Single answer
Review the recorded signal, check how recent the data is, and weigh the evidence before deciding.
A verified signal is not available for this stock. Missing data is not a Hold recommendation. Review the available company and price information and check back for an updated signal.
The stock is up 8.80 in the current move, which supports a stronger near-term tone.
There is not enough score context yet to rate conviction cleanly.
The stock has already moved 8.80 in the current move, so the hold view may not stay neutral for long.
Trading is running at 0.86x normal volume, so the move is worth watching but not fully confirmed.
Everything you need to act fast, in one glance.
Use these shifts to understand why the page leans buy, hold, or sell right now.
The stock is up 8.80 in the current move, which supports a stronger near-term tone.
These are the conditions most likely to weaken the current stock view.
The available indicators do not provide a complete risk assessment. Check company news, earnings dates and liquidity before deciding.
These are the next checks that matter if you want to follow the stock instead of reading it once.
The current signal was refreshed recently. A stable follow-through matters more than one isolated print.
Current trading is running at 0.86x normal pace. If that fades quickly, conviction can fade with it.
Compare public sector context, then sign in for completed-signal reliability and history.
How completed signals on this stock have behaved historically.
Create a free account to see how completed signals on this ticker have performed and whether the pattern deserves more trust.
See how the latest signal on this stock compares with other names in the same sector.
Across tracked names in Healthcare, the latest signals currently break down to 228 buy, 0 hold, and 154 sell.
See how the last completed signals on this ticker actually played out after they fired.
Create a free account to review the last completed signal outcomes on this ticker instead of relying on the current view alone.
The latest recorded technical signal:
We compare consensus targets with today's price.
Create a free account to follow analyst and signal changes on this stock over time.
Create free accountUse these cards to validate the signal, understand the business, and spot risks around the current verdict.
A quick overview of the business and its public profile.
NeurAxis Inc operates as a neuromodulation therapy device company in the United States It offers IBStim a percutaneous electrical nerve field stimulation system intended to be used in patients 1118 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics The company was formerly known as Innovative Health Solutions Inc and changed its name to NeurAxis Inc in March 2022 The company was founded in 2011 and is headquartered in Carmel Indiana
Start with the verdict and reason above. Use the method and analyst sections below to pressure-test the answer, not replace it.
The verdict displays the latest technical signal recorded for this ticker. Price history, trend, volume and analyst information provide separate context; they are not all inputs to a single verified forecast. See our methodology for data sources and limitations.
Check the signal date. Compare the price trend and volume with recent company news. Set a risk limit and identify what would make you change your decision. A signal can help organize the evidence, but it cannot remove uncertainty.
How Wall Street targets compare to today's price.
Create a free account to keep tracking stocks, follow signal changes, and use watchlist alerts.
Create free account